Jefferies Financial Group Trims Aurinia Pharmaceuticals (NASDAQ:AUPH) Target Price to $9.00
Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) had its price objective decreased by Jefferies Financial Group from $9.50 to $9.00 in a research report report published on Friday, BayStreet.CA reports. Jefferies Financial Group currently has a hold rating on the biotechnology company’s stock. Separately, Royal Bank of Canada lowered their price objective on Aurinia Pharmaceuticals […]
More Stories
iShares 1-3 Year Treasury Bond ETF (NASDAQ:SHY) Shares Acquired Sen. John Boozman
Senator John Boozman (R-Arkansas) recently bought shares of iShares 1-3 Year Treasury Bond ETF (NASDAQ:SHY). In a filing disclosed on...
Vanguard Small-Cap Value ETF (NYSEARCA:VBR) Shares Acquired by Iron Horse Wealth Management LLC
Iron Horse Wealth Management LLC boosted its position in Vanguard Small-Cap Value ETF (NYSEARCA:VBR – Free Report) by 3.8% in...
WhiteCoin (XWC) Price Reaches $0.0163 on Top Exchanges
WhiteCoin (XWC) traded 0.7% lower against the dollar during the 1-day period ending at 12:00 PM Eastern on October 23rd....
Frontier (FRONT) Reaches Self Reported Market Capitalization of $8.85 Million
Frontier (FRONT) traded 2.5% higher against the dollar during the 24-hour period ending at 12:00 PM ET on October 23rd....
Cobak Token Hits 24-Hour Trading Volume of $1.56 Million (CBK)
Cobak Token (CBK) traded 2.9% lower against the U.S. dollar during the one day period ending at 12:00 PM ET...
cVault.finance 1-Day Volume Hits $194.67 (CORE)
cVault.finance (CORE) traded flat against the dollar during the 1-day period ending at 12:00 PM Eastern on October 23rd. One...